Preparation and characterization of BSA-loaded liraglutide and platelet fragment nanoparticle delivery system for the treatment of diabetic atherosclerosis
BSA@LIR-PMF significantly inhibited diabetes-induced atherosclerosis. It was anticipated that the BSA@LIR-PMF nanoparticles might be used for treating diabetes-associated cardiovascular complications.
Authors
- Limin Fan (ORCID: https://orcid.org/0000-0002-0957-3097)
- Alimujiang Maimaitijiang (ORCID: https://orcid.org/0000-0002-4351-2992)
- Ming Fang (ORCID: https://orcid.org/0009-0001-7328-2024)
- Mingping He
Institutions
- Tongji University (CN)
- Fudan University (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Huadong Hospital (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1186/s12951-024-02775-z
- Citations
- 10
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.02